Loading
Total declarations
Companies
▲ Purchases (2 ops.)
▼ Sales (0 ops.)
Latest filing published 21 Feb 2024 for Celularity Inc, €21k.
Filing timeline
BuySaleAdrian Kilcoyne
Insider track record
Disclosed buys
2
Disclosed sells
0
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Adrian Kilcoyne: trading record in brief
Adrian Kilcoyne (senior executive) discloses dealings in 2 companies, chiefly Celularity Inc and Humanigen, Inc. In total, 5 filings cover trades dated from 8 March 2022 to 17 February 2024.
The open-market record is one-sided, with 2 purchases worth €29k and not one sale. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. Other entries cover 3 share grants.
The record was last updated on 21 February 2024 with a share grant (€21k) in Celularity Inc. The last purchase on record was published on 14 March 2022, which is 1,685 days ago. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 5 days. US insiders must file a Form 4 within two business days of a trade. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Companies and markets linked to Adrian Kilcoyne
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations4 total
52,762 shares@ US$0.434100.0% of flowClass A Common StockSEC:0001493152-24-007487:0
875,000 shares0Class A Common StockSEC:0000950170-23-033475:0
300,000 sharesClass A Common StockSEC:0000899243-23-005916:0
7,000 shares@ US$2.53100.0% of flowCommon StockSEC:0001214659-22-003919:0
Canonical exit: 6 Jun 2022 (T+90)
4 of 4 declarations
